Digital Drug Information: Easier Access and Choice of Format
This act aims to improve access to drug information by allowing manufacturers to provide it primarily digitally. Patients and healthcare providers will still be able to request paper leaflets free of charge. The changes seek to modernize the system and potentially reduce costs.
Key points
Drug information (leaflets) will be primarily available digitally, potentially allowing quicker access to updated data.
Patients and healthcare professionals retain the right to receive a paper version of the leaflet upon request, at no additional cost.
Regulations are designed to minimize negative economic impacts on prescribers and dispensers while modernizing the system.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.